Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1229.9000 20.30 (1.68%)
NSE Apr 30, 2025 14:31 PM
Volume: 651.1K
 

logo
Aurobindo Pharma Ltd.
04 Jun 2019
1229.90
1.68%
Business Line
Drug firm Aurobindo Pharma on Tuesday said it has received 10 observations from the US health regulator for its Unit 3 in Hyderabad.The United Stat
Aurobindo Pharma Ltd. has an average target of 1501.00 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market trades flat, Jana SFB's Q4FY25 net profit declines 61.6% YoY to Rs 123.5 crore
Trendlyne Marketwatch | 30 Apr 2025, 02:22PM
Five stocks to buy from analysts this week - April 29, 2025
The Baseline | 29 Apr 2025, 04:57PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020